The Patent Finder

Salix Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Salix Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 50 patents it holds.

Back to Salix Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US D715,422Automatic Injection Device
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,359,357Forms of Rifaximin and Uses Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,181,274Forms of Rifaximin and Uses Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,962,680Methods and Compositions for Treating HIV-Associated Diarrhea
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,585,868Methods and Compositions for Treating HIV-Associated Diarrhea
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,092,573Gastric and Colonic Formulations and Methods for Making and Using Them
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,507,517Forms of Rifaximin and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,364,467Rifaximin Derivative and Uses Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,725,466Rifaximin Derivative and Uses Thereof
Formerly held
In force
 · Low confidence
In forceLow confidence
US 7,452,872Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Term ended
Term ended Aug 24, 2026 · Medium confidence
Term endedTerm ended Aug 24, 2026Medium confidence
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited